Quartel Adrian W, Chief Medical Officer of ZeVra Therapeutics ($ZVRA), sold shares once on the open market in the last year, totaling about $40,000. His most recent sale occurred on January 30, 2026. These sales rank 10,608th among 11,678 insiders, well below the average of $8.6 million per person across about 6.4 transactions. He made no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 30, 2026 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Quartel Adrian W | Chief Medical Officer | S | Common Stock | 4533 | $8.83 | 9,723.0000 | 56,783,000 | 31.80% | 0.01% |
| Jan. 29, 2026 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Quartel Adrian W | Chief Medical Officer | A | Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 56,783,000 | 9999.99% | 0.13% |
| Jan. 30, 2026 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Quartel Adrian W | Chief Medical Officer | M | Restricted Stock Unit | 11333 | $0.00 | 22,667.0000 | 56,783,000 | 33.33% | 0.02% |
| Jan. 30, 2026 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Quartel Adrian W | Chief Medical Officer | M | Common Stock | 11333 | $0.00 | 14,256.0000 | 56,783,000 | 387.72% | 0.02% |
| Jan. 29, 2026 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Quartel Adrian W | Chief Medical Officer | A | Restricted Stock Unit | 37500 | $0.00 | 37,500.0000 | 56,783,000 | 9999.99% | 0.07% |
| Jan. 30, 2025 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Quartel Adrian W | Chief Medical Officer | A | Restricted Stock Unit | 34000 | $0.00 | 34,000.0000 | 47,808,817 | 9999.99% | 0.07% |
| Jan. 30, 2025 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Quartel Adrian W | Chief Medical Officer | A | Stock Option (right to buy) | 68000 | $0.00 | 68,000.0000 | 47,808,817 | 9999.99% | 0.14% |